Mavdol MR Tablet is a combination analgesic and muscle relaxant formulation containing Chlorzoxazone 250 mg, Diclofenac 50 mg, and Paracetamol 325 mg. This medication is indicated for the relief of musculoskeletal pain associated with muscle spasms, strains, and sprains. Chlorzoxazone acts centrally to relax skeletal muscles by depressing interneuronal activity in the spinal cord and subcortical areas of the brain, thereby reducing muscle spasm. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, leading to decreased synthesis of prostaglandins involved in pain and inflammation. Paracetamol contributes additional analgesic and antipyretic effects through central inhibition of prostaglandin synthesis. The combination offers synergistic relief by addressing pain, inflammation, and muscle spasm concurrently. Mavdol MR Tablet is typically administered orally, with dosing tailored to the severity of symptoms and patient response. Caution is advised in patients with hepatic, renal, or gastrointestinal disorders, and it should be used under medical supervision to minimize potential adverse effects such as gastrointestinal irritation, hepatotoxicity, or hypersensitivity reactions. This combination therapy is effective for short-term management of acute musculoskeletal conditions requiring multimodal analgesia and muscle relaxation.